As of 2025-05-17, the EV/EBITDA ratio of Bharat Immunologicals and Biologicals Corporation Ltd (524663.BO) is -9.53. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 524663.BO's latest enterprise value is 1,667.11 mil INR. 524663.BO's TTM EBITDA according to its financial statements is -174.93 mil INR. Dividing these 2 quantities gives us the above 524663.BO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 14.7x | 13.1x |
| Forward P/E multiples | 9.4x - 13.8x | 13.0x |
| Fair Price | (55.33) - (71.46) | (68.26) |
| Upside | -338.3% - -407.7% | -394.0% |
| Date | EV/EBITDA |